Э.Байгалмаа
Loading...
Товч нэр
Э.Байгалмаа
Бүтэн нэр
Эвсанаа Байгалмаа
Латин нэр
Evsanaa Baigalmaa
Албан тушаал
Багш
Scopus Author ID
5 results
Now showing 1 - 5 of 5
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Dialysis Outcomes Among Elderly Populations in Asian Countries(Mongolian National University of Medical Sciences, 2017-02-25); ;Khurtsbayar Damdinsuren; The inevitable reality of today is that the world population is aging, and the elderly (above 65 years) are more prevalent among the dialysis population worldwide. Objectives: The purpose of this review is to do a literature search on issues related to dialysis in the elderly Asian population, such as vascular access outcomes, complication rates, and survival data by modality on hemodialysis (HD) and peritoneal dialysis (PD). Methods: A literature search on key topic areas was done on articles published in English between January 1, 2005 and December 31, 2015. Results: Although incidences of elderly dialysis patients are increasing in Asia, we found that large-scale data is lacking. Further research is needed to assess dialysis outcomes among the elderly. Available studies suggest acceptable outcomes in vascular access, primary and secondary patency rates, and similar intervention rates compared to non-elderly. Survival data suggests superior outcomes in HD in elderly. Due to significant differences in dialysis practices in Asia, a proper comparison is difficult. Conclusion: Age alone is not a contraindication for dialysis. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 52 additional reference population samples for the 55 AISNP panel(2015-11) ;Pakstis, Andrew J ;Haigh, Eva ;Cherni, Lotfi ;ElGaaied, Amel Ben AmmarBarton, AlisonAncestry inference for a person using a panel of SNPs depends on the variation of frequencies of those SNPs around the world and the amount of reference data available for calculation/comparison. The Kidd Lab panel of 55 AISNPs has been incorporated in commercial kits by both Life Technologies and Illumina for massively parallel sequencing. Therefore, a larger set of reference populations will be useful for researchers using those kits. We have added reference population allele frequencies for 52 population samples to the 73 previously entered so that there are now allele frequencies publicly available in ALFRED and FROG-kb for a total of 125 population samples.Scopus© Citations 44 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, MgCaCO3 versus CaCO3 in peritoneal dialysis patients--a cross-over pilot trial(2015); ;Liu, Irene ;Aliazardeh, Babak ;Mahdavi, SaraBajwa, GursarnBACKGROUND: Despite adverse effects such as constipation, vascular calcification, and hypercalcemia, calcium-based salts are relatively affordable and effective phosphate binders that remain in widespread use in the dialysis population. We conducted a pilot study examining whether the use of a combined magnesium/calcium-based binder was as effective as calcium carbonate at lowering serum phosphate levels in peritoneal dialysis (PD) patients. METHODS: This was a cross-over, investigator-masked pilot study in which prevalent PD patients received calcium carbonate alone (200 mg calcium per tablet) or calcium magnesium carbonate (100 mg calcium, 85 mg magnesium per tablet). Primary outcome was serum phosphate level at 3 months. Analysis was as per protocol. RESULTS: Twenty patients were recruited, 17 completed the study. Mean starting dose was 11.35 ± 7.04 pills per day of MgCaCO3 and 9.00 ± 4.97 pills per day of CaCO3. Mean phosphate levels fell from 2.13 mmol/L to 2.01 mmol/L (95% confidence interval (CI): 1.76 - 2.30, p = 0.361) in the MgCaCO3 group, and 1.81 mmol/L (95% CI: 1.56 - 2.0, p = 0.026) in the CaCO3 alone group. Six (35%) patients taking MgCaCO3 and 9 (54%) taking CaCO3 alone achieved Kidney Disease Outcomes Quality Initiative (KDOQI) serum phosphate targets at 3 months. Diarrhea developed in 9 patients taking MgCaCO3 and 3 taking CaCO3. Serum magnesium exceeded 1.4 mmol/L in 5 patients taking MgCaCO3 while serum calcium exceeded 2.65 mmol/L in 3 patients receiving CaCO3. When compared to the initial dose, the prescribed dose at 3 months was reduced by 44% (to 6.41 tablets/day) in the MgCaCO3 group and by 8% (to 8.24 pills per day) in the CaCO3 alone group. CONCLUSION: Compared with CaCO3 alone, the preparation and dose of MgCaCO3 used in this pilot study was no better at lowering serum phosphate levels in PD patients, and was associated with more dose-limiting side effects.Scopus© Citations 12 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Ancestry inference of 96 population samples using microhaplotypes(2018-05) ;Bulbul, Ozlem ;Pakstis, Andrew J ;Soundararajan, Usha ;Gurkan, CemalBrissenden, Jane EMicrohaplotypes have become a new type of forensic marker with a great ability to identify and deconvolute mixtures because massively parallel sequencing (MPS) allows the alleles (haplotypes) of the multi-SNP loci to be determined directly for an individual. As originally defined, a microhaplotype locus is a short segment of DNA with two or more SNPs defining three or more haplotypes. The length is short enough, less than about 300 bp, that the read length of current MPS technology can produce a phase-known sequence of each chromosome of an individual. As part of the discovery phase of our studies, data on 130 microhaplotype loci with estimates of haplotype frequency data on 83 populations have been published. To provide a better picture of global allele frequency variation, we have now tested 13 more populations for 65 of the microhaplotype loci from among those with higher levels of inter-population gene frequency variation, including 8 loci not previously published. These loci provide clear distinctions among 6 biogeographic regions and provide some information distinguishing up to 10 clusters of populations.Scopus© Citations 61 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Mongolians in the Genetic Landscape of Central Asia: Exploring the Genetic Relations among Mongolians and Other World Populations(2015-04) ;Brissenden, Jane E ;Kidd, Judith R; ; Pakstis, Andrew JGenetic data on North and Central Asian populations are underrepresented in the literature, especially for autosomal markers. In the present study we used 812 single nucleotide polymorphisms (SNPs) distributed across all the human autosomes and extensively studied at Yale to examine the affinities of two recently collected samples of populations: rural and cosmopolitan Mongolians from Ulaanbaatar and nomadic, Turkic-speaking Tsaatan from Mongolia near the Siberian border. We compare these two populations with each other and with a global set of populations and discuss their relationships to New World populations. Specifically, we analyze data on 521 autosomal loci (single SNPs and multi-SNP haplotypes) studied in 57 populations representing all the major geographical regions of the world. We conclude that these North and Central Asian populations are genetically distinct from all other populations in our study and may be close to the ancestral lineage leading to the New World populations.Scopus© Citations 22
